Startup entity
regulation is the sole category represented across all 1 tracked stories. Richtech Robotics is most often covered alongside Mereo BioPharma, which appears in 1 of these 1 story. At 5, the average consequence score sits below the same-window beat average of 6.8.
Last mentioned: Mar 22, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
regulation is the sole category represented across all 1 tracked stories. Richtech Robotics is most often covered alongside Mereo BioPharma, which appears in 1 of these 1 story. At 5, the average consequence score sits below the same-window beat average of 6.8. They are less corroborated than the beat average, carrying 2 original sources each against 2.8 for the same window. Richtech Robotics appears in 1 tracked Startup story from March 22, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 25 Startup stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Richtech Robotics. Shared-story counts are live from our verified record — not editorial picks.
Pomerantz LLP has issued formal reminders regarding class action lawsuits filed against Richtech Robotics and Mereo BioPharma, alleging securities fraud and misleading disclosures. These legal maneuvers highlight the increasing scrutiny on post-IPO startups and clinical-stage biotech firms facing market volatility.
Richtech Robotics is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
